Capital Analysts LLC
PODD icon

Capital Analysts LLC’s Insulet PODD Stock Holding History

Capital Analysts LLC’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$210 – 1639
2026
Q1 		$210 Buy
+1
New +$251 ﹤0.01% 1567

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Analysts LLC's PODD Position: Q2 2026 in Review

Capital Analysts LLC sold out of Insulet (PODD) in Q2 2026, closing a stake of 1 share — an estimated $210 sold.

Capital Analysts LLC first reported a position in PODD in Q1 2026 and held it in 1 quarter. The position peaked at $210 in Q1 2026. 736 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Capital Analysts LLC reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 1 Insulet share in Q2 2026, an estimated $210.
  • Capital Analysts LLC first reported a position in Insulet in Q1 2026 and held it in 1 quarter.
  • Capital Analysts LLC's Insulet position peaked at $210 in Q1 2026.
  • 736 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.